BR0209796A - Moduladores de receptor ampa alostérico naftotiazina positivos (paarm) - Google Patents

Moduladores de receptor ampa alostérico naftotiazina positivos (paarm)

Info

Publication number
BR0209796A
BR0209796A BR0209796-6A BR0209796A BR0209796A BR 0209796 A BR0209796 A BR 0209796A BR 0209796 A BR0209796 A BR 0209796A BR 0209796 A BR0209796 A BR 0209796A
Authority
BR
Brazil
Prior art keywords
receptor modulators
paarm
naphthothiazine
positive allosteric
amp receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
BR0209796-6A
Other languages
English (en)
Inventor
Angelo Ceci
Klaus Klinder
Thomas Weiser
Karin Winter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH Co KG filed Critical Boehringer Ingelheim Pharma GmbH Co KG
Publication of BR0209796A publication Critical patent/BR0209796A/pt
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

"MODULADORES DE RECEPTOR AMPA ALOSTéRICO NAFTOTIAZINA POSITIVOS (PAARM)". A presente invenção refere-se a novos moduladores de receptor AMPA alostérico positivos de fórmula geral (I), em que R^ 1^, R^ 2^, R^ 3^, R^ 4^ e R^ 5^ podem ter os significados dados no relatório descritivo e nas reivindicações, processos para sua preparação e a utilização dos mesmos como composições farmacêuticas.
BR0209796-6A 2001-05-17 2002-05-15 Moduladores de receptor ampa alostérico naftotiazina positivos (paarm) Expired - Fee Related BR0209796A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10123952A DE10123952A1 (de) 2001-05-17 2001-05-17 Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
PCT/EP2002/005338 WO2002100411A1 (en) 2001-05-17 2002-05-15 Naphtothiazine positive allosteric ampa receptor modulators (paarm)

Publications (1)

Publication Number Publication Date
BR0209796A true BR0209796A (pt) 2004-06-01

Family

ID=7685080

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0209796-6A Expired - Fee Related BR0209796A (pt) 2001-05-17 2002-05-15 Moduladores de receptor ampa alostérico naftotiazina positivos (paarm)

Country Status (26)

Country Link
EP (1) EP1404340A1 (pt)
JP (1) JP2004529980A (pt)
KR (1) KR20040007572A (pt)
CN (1) CN1533278A (pt)
AR (1) AR036332A1 (pt)
BG (1) BG108324A (pt)
BR (1) BR0209796A (pt)
CA (1) CA2449189A1 (pt)
CO (1) CO5550460A2 (pt)
CZ (1) CZ20033112A3 (pt)
DE (1) DE10123952A1 (pt)
EA (1) EA006608B1 (pt)
EC (1) ECSP034852A (pt)
EE (1) EE200300566A (pt)
HR (1) HRP20030933A2 (pt)
HU (1) HUP0401273A3 (pt)
IL (1) IL158642A0 (pt)
MX (1) MXPA03010373A (pt)
NO (1) NO20035088L (pt)
NZ (1) NZ530154A (pt)
PL (1) PL364053A1 (pt)
SK (1) SK14222003A3 (pt)
UY (1) UY27290A1 (pt)
WO (1) WO2002100411A1 (pt)
YU (1) YU90403A (pt)
ZA (1) ZA200308466B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009002180A (es) * 2006-08-31 2009-06-05 Univ Alberta Metodo de inhibicion de la depresion respiratoria mediante el uso de moduladores alostericos positivos del receptor ampa.
CN111518058B (zh) * 2020-05-29 2021-03-09 四川大学华西医院 一种噁噻嗪类化合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4345297A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
AU4711899A (en) * 1998-06-25 2000-01-10 Merck & Co., Inc. Naphtho(1,8-de)thiasin-2-yl methyl carbapenem antibacterials
DE10004572A1 (de) * 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
WO2002100411A1 (en) 2002-12-19
KR20040007572A (ko) 2004-01-24
ECSP034852A (es) 2003-12-24
SK14222003A3 (sk) 2004-05-04
DE10123952A1 (de) 2002-11-21
EP1404340A1 (en) 2004-04-07
IL158642A0 (en) 2004-05-12
HRP20030933A2 (en) 2004-04-30
NO20035088D0 (no) 2003-11-14
NO20035088L (no) 2003-11-14
PL364053A1 (en) 2004-12-13
HUP0401273A3 (en) 2006-11-28
YU90403A (sh) 2006-05-25
MXPA03010373A (es) 2004-03-16
JP2004529980A (ja) 2004-09-30
CA2449189A1 (en) 2002-12-19
EA006608B1 (ru) 2006-02-24
EE200300566A (et) 2004-02-16
HUP0401273A2 (hu) 2004-10-28
ZA200308466B (en) 2004-05-24
CZ20033112A3 (en) 2004-03-17
NZ530154A (en) 2005-09-30
AR036332A1 (es) 2004-09-01
UY27290A1 (es) 2002-12-31
CN1533278A (zh) 2004-09-29
CO5550460A2 (es) 2005-08-31
EA200301167A1 (ru) 2004-06-24
BG108324A (bg) 2004-12-30

Similar Documents

Publication Publication Date Title
BR0108678A (pt) Novos compostos
BR0111667A (pt) Novos compostos
BR0308081A (pt) Inibidores de histona desacetilase
BRPI0113162B8 (pt) compostos ariloxialquilaminas nao-imidazólicos e composição farmacêutica compreendendo os referidos compostos
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
BR0108871A (pt) Composto, processo de preparação de compostos, e, composição farmacêutica
BR0307599A (pt) Derivados de sulfonilamino como inibidores de histona deacetilase
TR200101961T2 (tr) 1,2-halkalı kinolin türevleri
BR0209431A (pt) Novos compostos de 4-anilinoquinolino-3-carboxamidas
BRPI0108395B8 (pt) derivados de pirrolopirimidinona, processos de preparação e uso
BR0307575A (pt) Derivados de sulfonila como inibidores de histona desacetilase
BR0313041A (pt) Compostos; composições farmacêuticas; método para o tratamento e/ou profilaxia de doenças que estão associadas à modulação dos receptores de cb1; e uso de compostos
BR0109814A (pt) Derivados de indolin-2-ona e sua utilização como ligantes dos receptores da ocitocina
BR0214243A (pt) Derivado de sulfonamida processo para a preparação de um derivado de sulfonamida e seus sais fisiologicamente aceitáveis, composição farmacêutica e uso de um derivado de sulfonamida
BR9911013A (pt) Derivados de pirazol como inibidores da p-38 map quinase
BRPI0409109A (pt) novos compostos
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
BRPI0414514A (pt) uso de um composto, composto, e, composições farmacêuticas
BRPI0413094A (pt) derivados de quinolina e seu uso em terapia
BR0001292A (pt) Desfolhante
BRPI0417833A (pt) novos derivados de benzofurano, os quais podem ser usados na profilaxia ou tratamento de distúrbios relacionados com o receptor 5-ht6
BR0011831A (pt) Compostos, processo para preparar os mesmos, composições farmacêuticas, e, uso dos compostos
BR0214140A (pt) Derivados de piperidina e sua utilização como moduladores da atividade de receptor de quimiocina (especialmente ccr5)
UY30356A1 (es) Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos.
BRPI0406824A (pt) Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A , 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2029 DE 24/11/2009.